Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

SPARC is required for the maintenance of glucose homeostasis and insulin secretion in mice.

Atorrasagasti C, Onorato A, Gimeno ML, Andreone L, Garcia M, Malvicini M, Fiore E, Bayo J, Perone MJ, Mazzolini G.

Clin Sci (Lond). 2019 Jan 9. pii: CS20180714. doi: 10.1042/CS20180714. [Epub ahead of print]

PMID:
30626728
2.

SEOM clinical guidelines to primary prevention of cancer (2018).

Bayo J, Molina R, Pérez J, Pérez-Ruíz E, Aparicio J, Beato C, Berros JP, Bolaños M, Graña B, Santaballa A.

Clin Transl Oncol. 2019 Jan;21(1):106-113. doi: 10.1007/s12094-018-02016-4. Epub 2019 Jan 3.

PMID:
30607789
3.

Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks.

Bayo J, Tran TA, Wang L, Peña-Llopis S, Das AK, Martinez ED.

Cell Rep. 2018 Oct 23;25(4):1040-1050.e5. doi: 10.1016/j.celrep.2018.09.081.

4.

4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.

Rodríguez MM, Fiore E, Bayo J, Atorrasagasti C, García M, Onorato A, Domínguez L, Malvicini M, Mazzolini G.

Mol Ther. 2018 Dec 5;26(12):2738-2750. doi: 10.1016/j.ymthe.2018.09.012. Epub 2018 Sep 18.

PMID:
30301668
5.

Correction to: Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M.

Clin Transl Oncol. 2018 Dec;20(12):1631-1632. doi: 10.1007/s12094-018-1956-7.

PMID:
30284231
6.

Taking advantage of the potential of mesenchymal stromal cells in liver regeneration: Cells and extracellular vesicles as therapeutic strategies.

Fiore EJ, Domínguez LM, Bayo J, García MG, Mazzolini GD.

World J Gastroenterol. 2018 Jun 21;24(23):2427-2440. doi: 10.3748/wjg.v24.i23.2427. Review.

7.

Phytostabilization of polymetallic contaminated soil using Medicago sativa L. in combination with powdered marble: Sustainable rehabilitation.

Midhat L, Ouazzani N, Hejjaj A, Bayo J, Mandi L.

Int J Phytoremediation. 2018 Jul 3;20(8):764-772. doi: 10.1080/15226514.2018.1425665.

PMID:
29775105
8.

[Epigenetics and hepatocellular carcinoma: ¿a therapeutic opportunity?]

Bayo J, Mazzolini GD.

Medicina (B Aires). 2018;78(2):136-138. Spanish. No abstract available.

9.
10.

Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice.

Blancas I, Fontanillas M, Conde V, Lao J, Martínez E, Sotelo MJ, Jaen A, Bayo JL, Carabantes F, Illarramendi JJ, Gordon MM, Cruz J, García-Palomo A, Mendiola C, Pérez-Ruiz E, Bofill JS, Baena-Cañada JM, Jáñez NM, Esquerdo G, Ruiz-Borrego M.

Clin Transl Oncol. 2018 Jul;20(7):862-869. doi: 10.1007/s12094-017-1797-9. Epub 2017 Nov 24. Erratum in: Clin Transl Oncol. 2018 Dec;20(12):1631-1632.

PMID:
29178019
11.

Analysis of blood markers for early breast cancer diagnosis.

Bayo J, Castaño MA, Rivera F, Navarro F.

Clin Transl Oncol. 2018 Apr;20(4):467-475. doi: 10.1007/s12094-017-1731-1. Epub 2017 Aug 14.

PMID:
28808872
12.

Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors.

Dalvi MP, Wang L, Zhong R, Kollipara RK, Park H, Bayo J, Yenerall P, Zhou Y, Timmons BC, Rodriguez-Canales J, Behrens C, Mino B, Villalobos P, Parra ER, Suraokar M, Pataer A, Swisher SG, Kalhor N, Bhanu NV, Garcia BA, Heymach JV, Coombes K, Xie Y, Girard L, Gazdar AF, Kittler R, Wistuba II, Minna JD, Martinez ED.

Cell Rep. 2017 May 23;19(8):1669-1684. doi: 10.1016/j.celrep.2017.04.077.

13.

Involvement of hepatic macrophages in the antifibrotic effect of IGF-I-overexpressing mesenchymal stromal cells.

Fiore E, Malvicini M, Bayo J, Peixoto E, Atorrasagasti C, Sierra R, Rodríguez M, Gómez Bustillo S, García MG, Aquino JB, Mazzolini G.

Stem Cell Res Ther. 2016 Nov 22;7(1):172.

14.

IL-8, GRO and MCP-1 produced by hepatocellular carcinoma microenvironment determine the migratory capacity of human bone marrow-derived mesenchymal stromal cells without affecting tumor aggressiveness.

Bayo J, Real A, Fiore EJ, Malvicini M, Sganga L, Bolontrade M, Andriani O, Bizama C, Fresno C, Podhajcer O, Fernandez E, Gidekel M, Mazzolini GD, García MG.

Oncotarget. 2016 Jun 25;8(46):80235-80248. doi: 10.18632/oncotarget.10288. eCollection 2017 Oct 6.

15.

Principal factor and hierarchical cluster analyses for the performance assessment of an urban wastewater treatment plant in the Southeast of Spain.

Bayo J, López-Castellanos J.

Chemosphere. 2016 Jul;155:152-162. doi: 10.1016/j.chemosphere.2016.04.038. Epub 2016 Apr 22.

PMID:
27108373
16.

Comparison of Doctors' and Breast Cancer Patients' Perceptions of Docetaxel, Epirubicin, and Cyclophosphamide (TEC) Toxicity.

Bayo J, Prieto B, Rivera F.

Breast J. 2016 May;22(3):293-302. doi: 10.1111/tbj.12571. Epub 2016 Feb 11.

PMID:
26864346
17.

Perinatal and childhood factors and risk of breast cancer subtypes in adulthood.

Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM, Gracia-Lavedan E, Ederra M, Molina de la Torre AJ, LLorca FJ, Tardón A, Moreno V, Bayo J, Salas-Trejo D, Marcos-Gragera R, Pumarega J, Dierssen-Sotos T, Lera JP, de Miguel Medina MA, Tusquets I, Amiano P, Boldo E, Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M.

Cancer Epidemiol. 2016 Feb;40:22-30. doi: 10.1016/j.canep.2015.11.004. Epub 2015 Nov 21.

PMID:
26613540
18.

Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.

Bayo J, Dalvi MP, Martinez ED.

Future Med Chem. 2015;7(16):2243-61. doi: 10.4155/fmc.15.140. Epub 2015 Oct 29. Review.

PMID:
26510529
19.

Tumor Microenvironment Remodeling by 4-Methylumbelliferone Boosts the Antitumor Effect of Combined Immunotherapy in Murine Colorectal Carcinoma.

Malvicini M, Fiore E, Ghiaccio V, Piccioni F, Rizzo M, Olmedo Bonadeo L, García M, Rodríguez M, Bayo J, Peixoto E, Atorrasagasti C, Alaniz L, Aquino J, Matar P, Mazzolini G.

Mol Ther. 2015 Sep;23(9):1444-55. doi: 10.1038/mt.2015.112. Epub 2015 Jun 24.

20.

4-methylumbelliferone inhibits hepatocellular carcinoma growth by decreasing IL-6 production and angiogenesis.

Piccioni F, Fiore E, Bayo J, Atorrasagasti C, Peixoto E, Rizzo M, Malvicini M, Tirado-González I, García MG, Alaniz L, Mazzolini G.

Glycobiology. 2015 Aug;25(8):825-35. doi: 10.1093/glycob/cwv023. Epub 2015 Apr 16.

PMID:
25882295
21.

Discovering less toxic ionic liquids by using the Microtox® toxicity test.

Hernández-Fernández FJ, Bayo J, Pérez de los Ríos A, Vicente MA, Bernal FJ, Quesada-Medina J.

Ecotoxicol Environ Saf. 2015 Jun;116:29-33. doi: 10.1016/j.ecoenv.2015.02.034. Epub 2015 Mar 4.

PMID:
25748519
22.

SPARC (secreted protein acidic and rich in cysteine) knockdown protects mice from acute liver injury by reducing vascular endothelial cell damage.

Peixoto E, Atorrasagasti C, Aquino JB, Militello R, Bayo J, Fiore E, Piccioni F, Salvatierra E, Alaniz L, García MG, Bataller R, Corrales F, Gidekel M, Podhajcer O, Colombo MI, Mazzolini G.

Gene Ther. 2015 Jan;22(1):9-19. doi: 10.1038/gt.2014.102. Epub 2014 Nov 20.

23.

Mesenchymal stromal cells engineered to produce IGF-I by recombinant adenovirus ameliorate liver fibrosis in mice.

Fiore EJ, Bayo JM, Garcia MG, Malvicini M, Lloyd R, Piccioni F, Rizzo M, Peixoto E, Sola MB, Atorrasagasti C, Alaniz L, Camilletti MA, Enguita M, Prieto J, Aquino JB, Mazzolini G.

Stem Cells Dev. 2015 Mar 15;24(6):791-801. doi: 10.1089/scd.2014.0174. Epub 2014 Dec 3.

24.

Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.

Rizzo M, Bayo J, Piccioni F, Malvicini M, Fiore E, Peixoto E, García MG, Aquino JB, Gonzalez Campaña A, Podestá G, Terres M, Andriani O, Alaniz L, Mazzolini G.

PLoS One. 2014 Sep 19;9(9):e107944. doi: 10.1371/journal.pone.0107944. eCollection 2014.

25.

Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.

Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, Alaniz L, Piccioni F, Bolontrade M, Podhajcer O, Garcia MG, Mazzolini G.

Biomed Res Int. 2014;2014:837420. doi: 10.1155/2014/837420. Epub 2014 Jul 23.

26.

Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.

Salvador J, Manso L, de la Haba J, Jaen A, Ciruelos E, de Villena MC, Gil M, Murias A, Galan A, Jara C, Bayo J, Baena JM, Casal J, Mel JR, Blancas I, Sanchez Rvira P.

Clin Transl Oncol. 2015 Feb;17(2):160-6. doi: 10.1007/s12094-014-1210-x. Epub 2014 Aug 14.

PMID:
25119930
27.

Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.

Bayo J, Fiore E, Aquino JB, Malvicini M, Rizzo M, Peixoto E, Andriani O, Alaniz L, Piccioni F, Bolontrade M, Podhajcer O, Garcia MG, Mazzolini G.

PLoS One. 2014 Apr 15;9(4):e95171. doi: 10.1371/journal.pone.0095171. eCollection 2014.

28.

The therapeutic potential of bone marrow-derived mesenchymal stromal cells on hepatocellular carcinoma.

Bayo J, Marrodán M, Aquino JB, Silva M, García MG, Mazzolini G.

Liver Int. 2014 Mar;34(3):330-42. doi: 10.1111/liv.12338. Epub 2013 Oct 21. Review.

PMID:
24112437
29.

Lack of the matricellular protein SPARC (secreted protein, acidic and rich in cysteine) attenuates liver fibrogenesis in mice.

Atorrasagasti C, Peixoto E, Aquino JB, Kippes N, Malvicini M, Alaniz L, Garcia M, Piccioni F, Fiore EJ, Bayo J, Bataller R, Guruceaga E, Corrales F, Podhajcer O, Mazzolini G.

PLoS One. 2013;8(2):e54962. doi: 10.1371/journal.pone.0054962. Epub 2013 Feb 11.

30.

Chemoimmunotherapy for advanced gastrointestinal carcinomas: A successful combination of gene therapy and cyclophosphamide.

Malvicini M, Piccioni F, Bayo J, Fiore E, Atorrasagasti C, Alaniz L, Garcia M, Aquino JB, Gidekel M, Matar P, Mazzolini G.

Oncoimmunology. 2012 Dec 1;1(9):1626-1628.

31.

Single low-dose cyclophosphamide combined with interleukin-12 gene therapy is superior to a metronomic schedule in inducing immunity against colorectal carcinoma in mice.

Malvicini M, Alaniz L, Bayo J, Garcia M, Piccioni F, Fiore E, Atorrasagasti C, Aquino JB, Matar P, Mazzolini G.

Oncoimmunology. 2012 Oct 1;1(7):1038-1047.

32.
33.

Chemotherapy-induced nausea and vomiting: pathophysiology and therapeutic principles.

Bayo J, Fonseca PJ, Hernando S, Servitja S, Calvo A, Falagan S, García E, González I, de Miguel MJ, Pérez Q, Milena A, Ruiz A, Barnadas A.

Clin Transl Oncol. 2012 Jun;14(6):413-22. doi: 10.1007/s12094-012-0818-y. Review.

PMID:
22634529
34.

Antitumor effects of hyaluronic acid inhibitor 4-methylumbelliferone in an orthotopic hepatocellular carcinoma model in mice.

Piccioni F, Malvicini M, Garcia MG, Rodriguez A, Atorrasagasti C, Kippes N, Piedra Buena IT, Rizzo MM, Bayo J, Aquino J, Viola M, Passi A, Alaniz L, Mazzolini G.

Glycobiology. 2012 Mar;22(3):400-10. doi: 10.1093/glycob/cwr158. Epub 2011 Oct 28.

PMID:
22038477
35.

Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.

Garcia MG, Bayo J, Bolontrade MF, Sganga L, Malvicini M, Alaniz L, Aquino JB, Fiore E, Rizzo MM, Rodriguez A, Lorenti A, Andriani O, Podhajcer O, Mazzolini G.

Mol Pharm. 2011 Oct 3;8(5):1538-48. doi: 10.1021/mp200137c. Epub 2011 Aug 19.

PMID:
21770423
36.

Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.

Alaniz L, Rizzo M, Garcia MG, Piccioni F, Aquino JB, Malvicini M, Atorrasagasti C, Bayo J, Echeverria I, Sarobe P, Mazzolini G.

Cancer Immunol Immunother. 2011 Oct;60(10):1383-95. doi: 10.1007/s00262-011-1036-0. Epub 2011 Jun 3.

PMID:
21638126
37.

Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain.

Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, López-Solana J, Gállego M, Portús M, Gascón J; Chagas-Clot Research Group.

PLoS Negl Trop Dis. 2011 Apr 26;5(4):e1135. doi: 10.1371/journal.pntd.0001135.

38.

Reversal of gastrointestinal carcinoma-induced immunosuppression and induction of antitumoural immunity by a combination of cyclophosphamide and gene transfer of IL-12.

Malvicini M, Ingolotti M, Piccioni F, Garcia M, Bayo J, Atorrasagasti C, Alaniz L, Aquino JB, Espinoza JA, Gidekel M, Scharovsky OG, Matar P, Mazzolini G.

Mol Oncol. 2011 Jun;5(3):242-55. doi: 10.1016/j.molonc.2011.03.007. Epub 2011 Apr 5.

39.

Ecotoxicological screening of reclaimed disinfected wastewater by Vibrio fischeri bioassay after a chlorination-dechlorination process.

Bayo J, Angosto JM, Gómez-López MD.

J Hazard Mater. 2009 Dec 15;172(1):166-71. doi: 10.1016/j.jhazmat.2009.06.157. Epub 2009 Jul 4.

PMID:
19632038
40.

A multicentre phase II study to evaluate sequential docetaxel followed by capecitabine treatment in anthracycline-pretreated HER-2-negative patients with metastatic breast cancer.

Bayo J, Lomas M, Salvador J, Moreno A, Ruiz M, Rodríguez A, Fuentes J, Fernández-Freire A, Bernabé R, Fernández A.

Clin Transl Oncol. 2008 Dec;10(12):817-25.

PMID:
19068453
41.

Phase-II study of weekly schedule of trastuzumab, paclitaxel, and carboplatin followed by a week off every 28 days for HER2+ metastatic breast cancer.

Ruiz M, Salvador J, Bayo J, Lomas M, Moreno A, Valero M, Bernabé R, Vicente D, Jiménez J, Lopez-Ladrón A.

Cancer Chemother Pharmacol. 2008 Nov;62(6):1085-90. doi: 10.1007/s00280-008-0709-7. Epub 2008 Mar 26.

PMID:
18365200
42.

Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension.

Bayó J, Cos FX, Roca C, Dalfó A, Martín-Baranera MM, Albert B.

Blood Press Monit. 2006 Apr;11(2):47-52.

PMID:
16534404
43.

Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial.

Pelegrí A, Calvo L, Antón A, Mayordomo JI, Florián J, Vásquez S, Arcusa A, Martín-Richard M, Bayo JL, Carrasco E, Virizuela J; Spanish Group for Breast Cancer Research (GEICAM).

Clin Breast Cancer. 2005 Dec;6(5):433-8.

PMID:
16381627
44.

The impact of a monophasic continuous estro-progestogenic treatment on Latin American menopausal women.

Bassol S, Carranza-Lira S, Celis-Gonzalez C, Santoyo S, Murillo A, Martinez N, Santos J, Llaca V, de la Loza FR, Zarain J, da Fonseca AM, Camargos AF, Baracat EC, da Sá MF, Bayo J, Adaro L, Gurucharri C, Murga M, Siseles N, Sayegh F, Tempone A, Tempone LM, Tozzini RI, Boccanera R, Naranjo C, Sanchez F, Gomez G, Blanco S, Reyes-Marquez R, Albrecht G, Rios PC.

Maturitas. 2005 Mar 14;50(3):189-95.

PMID:
15734600
45.

Gemcitabine plus docetaxel administered every other week as first-line treatment of metastatic breast cancer: preliminary results from a phase II trial.

Pelegrí A, Calvo L, Mayordomo JI, Florián J, Vázquez S, Arcusa A, Martn-Richard M, Bayo JL, Virizuela J, Carrasco E, Antón A; Spanish Group for Breast Cancer Research (GEICAM).

Semin Oncol. 2004 Apr;31(2 Suppl 5):20-4.

PMID:
15199528
46.

[Study of the accumulation of lead in the primary teeth].

Aguinaga I, Manso E, Guillén F, Viñes JJ, Guillén JJ, Martínez MJ, Pérez de Ciriza JA, Brun C, Marín B, Herrera T, García-Marco L, Bayo J; Grupo EPLODIN.

An Sist Sanit Navar. 2000 Jan-Apr;23(1):19-24. Spanish.

47.

[European regulations and the future of mercury sphygmomanometers in the clinical setting].

Vinyoles E, Armengol F, Bayó J, Mengual L, Salvadó A, Pepió JM; Grupo de Hipertensión de la Societat Catalana de Medicina Familiar i Comunitària.

Med Clin (Barc). 2003 Apr 5;120(12):460-3. Spanish. No abstract available.

PMID:
12689554
48.

Immunocytochemical localization of allergenic proteins from mature to activated Zygophyllum fabago L. (Zygophyllaceae) pollen grains.

Castells T, Arcalís E, Moreno-Grau S, Bayo J, Elvira-Rendueles B, Belchí J, Seoane-Camba JA, Suárez-Cervera M.

Eur J Cell Biol. 2002 Feb;81(2):107-15.

PMID:
11893081
49.

Environmental and physiological factors affecting lead and cadmium levels in deciduous teeth.

Bayo J, Moreno-Grau S, Martinez MJ, Moreno J, Angosto JM, Guillén Pérez J, Garcia Marcos L, Moreno-Clavel J.

Arch Environ Contam Toxicol. 2001 Aug;41(2):247-54.

PMID:
11462151
50.

Electroanalytical determination of cadmium and lead in deciduous teeth after microwave oven digestion.

Bayo J, Moreno-Grau S, Martínez MJ, Moreno J, Angosto JM, Moreno-Clavel J, Guillén Pérez JJ, García Marcos L.

J AOAC Int. 2001 Jan-Feb;84(1):111-6.

PMID:
11234796

Supplemental Content

Support Center